Inner medullary expression of AQP2 and p-AQP2. by Sophie Constantin Lütken (689916)

Subjects:

Inner medullary expression of the Gsα subunit. by Sophie Constantin Lütken (689916)

Subjects:

Inner medullary expression of the (pro)renin receptor. by Sophie Constantin Lütken (689916)

Subjects:

Representative examples of LBNP and LBPP/hypoxia experiment. by Marcus Thudium (6441863)

Characterization of the optimized nanoparticles (These values are means of a minimum of 5 batches). by Anjuman Arora (750291)

Inner medullary expression of AQP1. by Sophie Constantin Lütken (689916)

Subjects:

Inner medullary expression of AQP4. by Sophie Constantin Lütken (689916)

Subjects:

Inner medullary expression of the type 1_A angiotensin II receptor. by Sophie Constantin Lütken (689916)

Subjects:

Chronic high glucose induces apoptosis and proteasome activities decrease in INS-1E cells. by Christophe Broca (538652)

Chronic high glucose induces apoptosis and proteasome activities decrease in INS-1E cells. by Christophe Broca (538652)

Post treatment echocardiagraphic parameters. by Sophie Constantin Lütken (689916)

Subjects:

Procaspase 8 inducing drugs decrease total HIV DNA <i>ex vivo</i>. by Rahul Sampath (4117297)

Changes in renal function. by Sophie Constantin Lütken (689916)

Subjects:

Downregulation of LGR4 decreases ARPE-19 cell migration. by Qiang Hou (495704)

The decreased permeability caused by phospholipid content in the membrane could drive the emergence of other functions in the protocells. by Wentao Ma (326530)

B-RAF inhibitor PLX4720 decreased hERG currents in rhabdomyosarcoma RD cells. by Tatsiana Pakladok (311653)

Treatment with rSFRP4 results in decreased migration and increased adhesion of ovarian cancer cells. by Caroline E. Ford (289563)

PLE-mediated ICP1 inhibition blocks phage burst and decreases phage genome replication. by Brendan J. O’Hara (4096459)

mGluR5 receptor decreased glycinergic currents. by Zi-Yang Zhang (4988555)

“…<p>(<b>A–B</b>) Bath perfusion of DHPG for 3 min reduced GlyR-IPSCs (<b>A</b>; 70.2 ± 4.2% of baseline at 15–20 min post-DHPG, <i>t</i>[16] = 6.707, <i>p</i> < 0.001, paired Student <i>t</i> test), but not GABA_A-receptor–mediated IPSCs (<b>B</b>; 102.9 ± 3.3% of baseline at 15–20 min post-DHPG, <i>t</i>[5] = 0.347, <i>p</i> = 0.743) in spinal slices of mice. …”

Percentage of normal/intermediate/poor metabolizers, or persons with decreased or poor transporter function of SLCO1B1 or reduced expression of VKORC1, showing high proportions of... by Riccardo Proietti (15332861)